These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8277796)

  • 1. Antibody to hepatitis C virus in thalassemia patients.
    Isahak I; Baharin R; Hakim AS; Abu Bakar M; George E
    Malays J Pathol; 1993 Jun; 15(1):85-7. PubMed ID: 8277796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia.
    Alavian SM; Miri SM; Keshvari M; Elizee PK; Behnava B; Tabatabaei SV; Lankarani KB
    Transfusion; 2009 Oct; 49(10):2195-9. PubMed ID: 19538541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation.
    Erer B; Angelucci E; Lucarelli G; Giardini C; Baronciani D; Galimberti M; Polchi P; Amadei G; Battistini L; Paolucci S
    Bone Marrow Transplant; 1994 Sep; 14(3):369-72. PubMed ID: 7527690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
    Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
    Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A seroprevalence study of the hepatitis C virus among multiply transfused patients].
    Antipa C; Popescu A; Teleguţă M; Ruţă S; Cernescu C; Târdei G; Copelovici Y; Stoian M; Tivgă N; Hoinărescu M
    Rev Roum Virol; 1993; 44(1-2):9-15. PubMed ID: 8043483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus antibody in multiply transfused Chinese with thalassaemia major.
    Lau YL; Chow CB; Lee AC; Ng KW; Lim WL; Chan CF; Lam SY; Li CK
    Bone Marrow Transplant; 1993; 12 Suppl 1():26-8. PubMed ID: 7690634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C virus antibodies in patients following blood transfusion and kidney transplantation].
    Baur P; Daniel V; Pomer S; Scheurlen H; Opelz G; Roelcke D
    Beitr Infusionsther; 1991; 28():27-8. PubMed ID: 1725637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
    Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
    Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the patients with low levels of anti-HCV positivity].
    Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
    Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan.
    Chiou SS; Huang JF; Chang TT; Hsieh MY; Dai CY; Yu ML; Chang WY; Chuang WL
    Digestion; 2006; 74(3-4):208-14. PubMed ID: 17341855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of transfusion-associated hepatitis C in a children's hospital.
    Luban NL; Colvin CA; Mohan P; Alter HJ
    Transfusion; 2007 Apr; 47(4):615-20. PubMed ID: 17381619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
    Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK
    Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.